Post PCI anti-thrombotic strategies

Anchorperson: A. Greco
Spokesperson: B. Lattuca
SHOW MORE

Learning Objectives

  • To define the bleeding and thrombotic risk profiles of a particular patient
  • To be able to choose the best early thrombotic therapy of an ACS patient with high risk of bleeding and thrombosis
  • To be able to choose the best chronic antithrombotic therapy of a chronic coronary syndrome patient with high risk of bleeding and thrombosis

Presentations available when logged in:

  • Session objectives
  • Clinical segment 1: a “birisk” patient with ACS
  • Evidence: antiplatelet therapy selection in ACS
  • Clinical segment 2: selecting antithrombotic therapy
  • Clinical segment 3: a “birisk” patient with chronic coronary syndrome
  • Evidence: antiplatelet therapy selection in chronic coronary syndrome
  • Clinical segment 4: selecting antithrombotic therapy
  • Session evaluation and key learnings